The classification and diagnosis of cutaneous lupus erythematosus

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 14-19

  Kuhn, Annegret ^a,b   Landmann, Aysche ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Classification; Cutaneous lupus erythematosus; Diagnosis; Skin

Indexed keywords

ANTINUCLEAR ANTIBODY;

ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS; ARTICLE; BILAG SCORE; CHILBLAIN; CHILBLAIN LUPUS ERYTHEMATOSUS; CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ECLAM SCORE; ELECTROCARDIOGRAM; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; EPIDEMIOLOGICAL DATA; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; INCIDENCE; INTERMITTENT CUTANEOUS LUPUS ERYTHEMATOSUS; LABORATORY TEST; LUPUS ERYTHEMATOSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANNICULITIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROVOCATION TEST; SKIN BIOPSY; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS; SKIN ULCER; SLEDAI; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET A RADIATION;

CLASSIFICATION; CUTANEOUS LUPUS ERYTHEMATOSUS; DIAGNOSIS; SKIN;

ACUTE DISEASE; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; PANNICULITIS; SEVERITY OF ILLNESS INDEX; SKIN ABNORMALITIES; ULTRAVIOLET RAYS;

EID: 84895871942     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.021     Document Type: Article

References (51)

1. Jimenez S., Cervera R., Ingelmo M., Font J. The epidemiology of cutaneous lupus erythematosus. Cutaneous lupus erythematosus 2004, 45-52. Springer-Verlag, Berlin. A. Kuhn, P. Lehmann, T. Ruzicka (Eds.).
2. Tebbe B., Orfanos C.E. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997, 6:96-104.
3. Popovic K., Nyberg F., Wahren-Herlenius M. Aserology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis Rheum 2007, 56:255-264.
4. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
5. Albrecht J., Berlin J.A., Braverman I.M., Callen J.P., Connolly M.K., Costner M.I., et al. Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus 2004, 13:839-849.
6. Petri M., Orbai A.M., Alarcon G.S., Gordon C., Merrill J.T., Fortin P.R., et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012, 64:2677-2686.
7. Gilliam J.N., Sontheimer R.D. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. JAm Acad Dermatol 1981, 4:471-475.
8. Provost T.T. Nonspecific cutaneous manifestations of systemic lupus erythematosus. Cutaneous lupus erythematosus 2004, 93-106. Springer, Heidelberg. A. Kuhn, P. Lehmann, T. Ruzicka (Eds.).
9. Kuhn A., Ruzicka T. Classification of cutaneous lupus erythematosus. Cutaneous lupus erythematosus 2004, 53-58. Springer-Verlag, Berlin. A. Kuhn, P. Lehmann, T. Ruzicka (Eds.).
10. Werth V.P. Cutaneous lupus: insights into pathogenesis and disease classification. Bull NYU Hosp Jt Dis 2007, 65:200-204.
11. Sontheimer R.D. The lexicon of cutaneous lupus erythematosus - a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997, 6:84-95.
12. Schmitt V., Meuth A.M., Amler S., Kuehn E., Haust M., Messer G., et al. Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus. Br J Dermatol 2010, 162:64-73.
13. Kuhn A., Bein D., Bonsmann G. The 100th anniversary of lupus erythematosus tumidus. Autoimmun Rev 2009, 8:441-448.
14. Rodriguez-Caruncho C., Bielsa I. Lupus erythematosus tumidus: a clinical entity still being defined. Actas Dermosifiliogr 2011, 102:668-674.
15. Kuhn A., Kuehn E., Meuth A.M., Haust M., Nyberg F., Werth V., et al. Development of a core set questionnaire by the European Society of cutaneous lupus erythematosus (EUSCLE). Autoimmun Rev 2009, 8:702-712.
16. Kuhn A., Patsinakidis N., Bonsmann G. The impact of the EUSCLE core set questionnaire for the assessment of cutaneous lupus erythematosus. Lupus 2010, 19:1144-1152.
17. Biazar C., Sigges J., Patsinakidis N., Ruland V., Amler S., Bonsmann G., et al. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev 2013, 12:444-454.
18. Sigges J., Biazar C., Landmann A., Ruland V., Patsinakidis N., Amler S., et al. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) core set questionnaire in more than 1000 patients with cutaneous lupus erythematosus. Autoimmun Rev 2013, 12:694-702.
19. Kuhn A., Lehmann P., Ruzicka T. Clinical manifestations of cutaneous lupus erythematosus. Cutaneous lupus erythematosus 2004, 59-92. Springer, Heidelberg. A. Kuhn, P. Lehmann, T. Ruzicka (Eds.).
20. Werth V.P. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev 2005, 4:296-302.
21. Horne N.S., Narayan A.R., Young R.M., Frieri M. Toxic epidermal necrolysis in systemic lupus erythematosus. Autoimmun Rev 2006, 5:160-164.
22. Sontheimer R.D. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 2005, 4:253-263.
23. Milde P., Goerz G. Depigmentation in lupus erythematodes (LE) - clinical "clue" of subacute cutaneous lupus erythematosus (SCLE). ZHautkr 1994, 69:123-126.
24. Sontheimer R.D., Henderson C.L., Grau R.H. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 2009, 301:65-70.
25. Gronhagen C.M., Fored C.M., Linder M., Granath F., Nyberg F. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Br J Dermatol 2012, 167:296-305.
26. Wiznia L.E., Subtil A., Choi J.N. Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent. JAMA Dermatol 2013, 149:1071-1075.
27. Tebbe B., Mansmann U., Wollina U., Auer-Grumbach P., Licht-Mbalyohere A., Arsenmeier M., et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol 1997, 77:305-308.
28. Costner M.I., Sontheimer R.D., Provost T.T. Lupus erythematosus. Cutaneous manifestations of rheumatic diseases 2003, 15-64. Williams & Wilkins, Philadelphia. R.D. Sontheimer, T.T. Provost (Eds.).
29. Al-Refu K., Goodfield M. Hair follicle stem cells in the pathogenesis of the scarring process in cutaneous lupus erythematosus. Autoimmun Rev 2009, 8:474-477.
30. Arai S., Katsuoka K. Clinical entity of lupus erythematosus panniculitis/lupus erythematosus profundus. Autoimmun Rev 2009, 8:449-452.
31. Viguier M., Pinquier L., Cavelier-Balloy B., de la Salmoniere P., Cordoliani F., Flageul B., et al. Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus. Medicine (Baltimore) 2001, 80:180-188.
32. Kuhn A., Richter-Hintz D., Oslislo C., Ruzicka T., Megahed M., Lehmann P. Lupus erythematosus tumidus - a neglected subset of cutaneous lupus erythematosus: report of 40 cases. Arch Dermatol 2000, 136:1033-1041.
33. Kuhn A., Ruland V., Bonsmann G. Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus. Lupus 2010, 19:1036-1046.
34. Griffiths B., Mosca M., Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005, 19:685-708.
35. Ward M.M., Marx A.S., Barry N.N. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. JRheumatol 2000, 27:664-670.
36. Albrecht J., Taylor L., Berlin J.A., Dulay S., Ang G., Fakharzadeh S., et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. JInvest Dermatol 2005, 125:889-894.
37. Kuhn A., Meuth A.M., Bein D., Amler S., Beissert S., Bohm M., et al. Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol 2010, 163:83-92.
38. Walling H.W., Sontheimer R.D. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009, 10:365-381.
39. Sticherling M., Bonsmann G., Kuhn A. Diagnostic approach and treatment of cutaneous lupus erythematosus. JDtsch Dermatol Ges 2008, 6:48-59.
40. Obermoser G., Sontheimer R.D., Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus 2010, 19:1050-1070.
41. Ackermann A.B. Lupus erythematosus. Histologic diagnosis of inflammatory skin diseases 1997, 525-546. Williams & Wilkins, Baltimore.
42. Gonzalez E.G., Selvi E., Lorenzini S., Maggio R., Mannucci S., Galeazzi M., et al. Subcutaneous panniculitis-like T-cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clin Rheumatol 2007, 26:244-246.
43. Kuhn A., Sonntag M., Ruzicka T., Lehmann P., Megahed M. Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. JAm Acad Dermatol 2003, 48:901-908.
44. Cardinali C., Caproni M., Fabbri P. The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus. Clin Exp Rheumatol 1999, 17:427-432.
45. Cardinali C., Caproni M., Fabbri P. The composition of the lupus band test (LBT) on the sun-protected non-lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE). Lupus 1999, 8:755-760.
46. Weyd H., Abeler-Dorner L., Linke B., Mahr A., Jahndel V., Pfrang S., et al. Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity. PLoS One 2013, 8:e62449.
47. Kretz C.C., Norpo M., Abeler-Dorner L., Linke B., Haust M., Edler L., et al. Anti-annexin 1 antibodies: a new diagnostic marker in the serum of patients with discoid lupus erythematosus. Exp Dermatol 2010, 19:919-921.
48. Kuhn A., Wozniacka A., Szepietowski J.C., Glaser R., Lehmann P., Haust M., et al. Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. JInvest Dermatol 2011, 131:1622-1630.
49. Kuhn A., Sonntag M., Richter-Hintz D., Oslislo C., Megahed M., Ruzicka T., et al. Phototesting in lupus erythematosus: a 15-year experience. JAm Acad Dermatol 2001, 45:86-95.
50. Ruland V., Haust M., Stilling R.M., Amler S., Ruzicka T., Kuhn A. Updated analysis of standardised photoprovocation in patients with cutaneous lupus erythematosus. Arthritis Care Res 2012, 65:767-776.
51. Mosca M., Tani C., Aringer M., Bombardieri S., Boumpas D., Brey R., et al. European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010, 69:1269-1274.